207 related articles for article (PubMed ID: 27563399)
1. Stereochemistry Balances Cell Permeability and Solubility in the Naturally Derived Phepropeptin Cyclic Peptides.
Schwochert J; Lao Y; Pye CR; Naylor MR; Desai PV; Gonzalez Valcarcel IC; Barrett JA; Sawada G; Blanco MJ; Lokey RS
ACS Med Chem Lett; 2016 Aug; 7(8):757-61. PubMed ID: 27563399
[TBL] [Abstract][Full Text] [Related]
2. Cell permeability beyond the rule of 5.
Matsson P; Doak BC; Over B; Kihlberg J
Adv Drug Deliv Rev; 2016 Jun; 101():42-61. PubMed ID: 27067608
[TBL] [Abstract][Full Text] [Related]
3. Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs.
Danelius E; Poongavanam V; Peintner S; Wieske LHE; Erdélyi M; Kihlberg J
Chemistry; 2020 Apr; 26(23):5231-5244. PubMed ID: 32027758
[TBL] [Abstract][Full Text] [Related]
4. Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5.
Rossi Sebastiano M; Doak BC; Backlund M; Poongavanam V; Over B; Ermondi G; Caron G; Matsson P; Kihlberg J
J Med Chem; 2018 May; 61(9):4189-4202. PubMed ID: 29608068
[TBL] [Abstract][Full Text] [Related]
5. Managing Experimental 3D Structures in the Beyond-Rule-of-5 Chemical Space: The Case of Rifampicin.
Ermondi G; Lavore F; Vallaro M; Tiana G; Vasile F; Caron G
Chemistry; 2021 Jul; 27(40):10394-10404. PubMed ID: 34114271
[TBL] [Abstract][Full Text] [Related]
6. Solubility prediction in the bRo5 chemical space: where are we right now?
Ermondi G; Poongavanam V; Vallaro M; Kihlberg J; Caron G
ADMET DMPK; 2020; 8(3):207-214. PubMed ID: 35300306
[TBL] [Abstract][Full Text] [Related]
7. Steering New Drug Discovery Campaigns: Permeability, Solubility, and Physicochemical Properties in the bRo5 Chemical Space.
Caron G; Kihlberg J; Goetz G; Ratkova E; Poongavanam V; Ermondi G
ACS Med Chem Lett; 2021 Jan; 12(1):13-23. PubMed ID: 33488959
[TBL] [Abstract][Full Text] [Related]
8. Design Principles for Balancing Lipophilicity and Permeability in beyond Rule of 5 Space.
Möbitz H
ChemMedChem; 2024 Mar; 19(5):e202300395. PubMed ID: 37986275
[TBL] [Abstract][Full Text] [Related]
9. Updating the portfolio of physicochemical descriptors related to permeability in the beyond the rule of 5 chemical space.
Ermondi G; Vallaro M; Goetz G; Shalaeva M; Caron G
Eur J Pharm Sci; 2020 Apr; 146():105274. PubMed ID: 32088315
[TBL] [Abstract][Full Text] [Related]
10. Can small drugs predict the intrinsic aqueous solubility of 'beyond Rule of 5' big drugs?
Avdeef A; Kansy M
ADMET DMPK; 2020; 8(3):180-206. PubMed ID: 35300304
[TBL] [Abstract][Full Text] [Related]
11. Cyclic Peptide Design Guided by Residual Dipolar Couplings, J-Couplings, and Intramolecular Hydrogen Bond Analysis.
Farley KA; Che Y; Navarro-Vázquez A; Limberakis C; Anderson D; Yan J; Shapiro M; Shanmugasundaram V; Gil RR
J Org Chem; 2019 Apr; 84(8):4803-4813. PubMed ID: 30605335
[TBL] [Abstract][Full Text] [Related]
12. Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides.
Rezai T; Bock JE; Zhou MV; Kalyanaraman C; Lokey RS; Jacobson MP
J Am Chem Soc; 2006 Nov; 128(43):14073-80. PubMed ID: 17061890
[TBL] [Abstract][Full Text] [Related]
13. Design Principles for Intestinal Permeability of Cyclic Peptides.
Mathiowetz AM
Methods Mol Biol; 2019; 2001():1-15. PubMed ID: 31134564
[TBL] [Abstract][Full Text] [Related]
14. Chamelogk: A Chromatographic Chameleonicity Quantifier to Design Orally Bioavailable Beyond-Rule-of-5 Drugs.
Garcia Jimenez D; Vallaro M; Rossi Sebastiano M; Apprato G; D'Agostini G; Rossetti P; Ermondi G; Caron G
J Med Chem; 2023 Aug; 66(15):10681-10693. PubMed ID: 37490408
[TBL] [Abstract][Full Text] [Related]
15. Going Out on a Limb: Delineating The Effects of β-Branching, N-Methylation, and Side Chain Size on the Passive Permeability, Solubility, and Flexibility of Sanguinamide A Analogues.
Bockus AT; Schwochert JA; Pye CR; Townsend CE; Sok V; Bednarek MA; Lokey RS
J Med Chem; 2015 Sep; 58(18):7409-18. PubMed ID: 26308180
[TBL] [Abstract][Full Text] [Related]
16. Opportunities and guidelines for discovery of orally absorbed drugs in beyond rule of 5 space.
Poongavanam V; Doak BC; Kihlberg J
Curr Opin Chem Biol; 2018 Jun; 44():23-29. PubMed ID: 29803972
[TBL] [Abstract][Full Text] [Related]
17. Cell-permeable chameleonic peptides: Exploiting conformational dynamics in de novo cyclic peptide design.
Ramelot TA; Palmer J; Montelione GT; Bhardwaj G
Curr Opin Struct Biol; 2023 Jun; 80():102603. PubMed ID: 37178478
[TBL] [Abstract][Full Text] [Related]
18. Isolation and structural determination of phepropeptins A, B, C, and D, new proteasome inhibitors, produced by Streptomyces sp.
Sekizawa R; Momose I; Kinoshita N; Naganawa H; Hamada M; Muraoka Y; Iinuma H; Takeuchi T
J Antibiot (Tokyo); 2001 Nov; 54(11):874-81. PubMed ID: 11827028
[TBL] [Abstract][Full Text] [Related]
19. Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?
Poongavanam V; Danelius E; Peintner S; Alcaraz L; Caron G; Cummings MD; Wlodek S; Erdelyi M; Hawkins PCD; Ermondi G; Kihlberg J
ACS Omega; 2018 Sep; 3(9):11742-11757. PubMed ID: 30320271
[TBL] [Abstract][Full Text] [Related]
20. Geometrically Diverse Lariat Peptide Scaffolds Reveal an Untapped Chemical Space of High Membrane Permeability.
Kelly CN; Townsend CE; Jain AN; Naylor MR; Pye CR; Schwochert J; Lokey RS
J Am Chem Soc; 2021 Jan; 143(2):705-714. PubMed ID: 33381960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
